Literature DB >> 34091125

The relationship of glucose-stimulated insulin secretion to cerebral glucose metabolism and cognition in healthy middle-aged and older adults.

Gilda E Ennis1, Akshay Kohli2, Erin M Jonaitis3, Tobey J Betthauser2, Jennifer M Oh2, Chase E Taylor2, Nathaniel Chin4, Rebecca L Koscik3, Bradley T Christian5, Sanjay Asthana6, Sterling C Johnson6, Barbara B Bendlin6.   

Abstract

Insulin resistance (IR) has been related to reduced cerebral glucose metabolism in regions identified as hypometabolic in Alzheimer's clinical syndrome. Insulin secretion (IS) has been less studied than IR despite findings that decreased IS is an early indicator of future type 2 diabetes and a potential predictor of Alzheimer's clinical syndrome. We investigated whether higher IR and lower IS would be associated with greater age-related reductions in regional cerebral glucose metabolism and worse cognitive performance. Two-hour oral glucose tolerance testing and 18F-fluorodeoxyglucose positron emission tomography were performed on 1-2 occasions on a sample of healthy middle-aged and older adults from the Wisconsin Alzheimer's Disease Research Center. Neuropsychological tests were completed during Alzheimer's Disease Research Center Clinical Core visits. Pattern of findings suggested that lower (not higher) IS was related to higher regional cerebral glucose metabolism in middle aged but not older adults, and lower (not higher) IS was also related to better immediate recall. In the context of healthy insulin sensitivity, lower IS may be beneficial to brain health.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aging; Cerebral glucose metabolism; Cognition; Insulin secretion

Mesh:

Substances:

Year:  2021        PMID: 34091125      PMCID: PMC8338794          DOI: 10.1016/j.neurobiolaging.2021.04.028

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   5.133


  71 in total

1.  Insulin resistance is associated with the pathology of Alzheimer disease: the Hisayama study.

Authors:  T Matsuzaki; K Sasaki; Y Tanizaki; J Hata; K Fujimi; Y Matsui; A Sekita; S O Suzuki; S Kanba; Y Kiyohara; T Iwaki
Journal:  Neurology       Date:  2010-08-25       Impact factor: 9.910

2.  High fat diet produces brain insulin resistance, synaptodendritic abnormalities and altered behavior in mice.

Authors:  Steven E Arnold; Irwin Lucki; Bethany R Brookshire; Gregory C Carlson; Caroline A Browne; Hala Kazi; Sookhee Bang; Bo-Ran Choi; Yong Chen; Mary F McMullen; Sangwon F Kim
Journal:  Neurobiol Dis       Date:  2014-03-29       Impact factor: 5.996

3.  Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes.

Authors:  Laura D Baker; Donna J Cross; Satoshi Minoshima; Dana Belongia; G Stennis Watson; Suzanne Craft
Journal:  Arch Neurol       Date:  2010-09-13

Review 4.  Compensatory hyperinsulinemia and the development of an atherogenic lipoprotein profile: the price paid to maintain glucose homeostasis in insulin-resistant individuals.

Authors:  Gerald M Reaven
Journal:  Endocrinol Metab Clin North Am       Date:  2005-03       Impact factor: 4.741

Review 5.  The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads converged.

Authors:  Suzanne Craft
Journal:  Arch Neurol       Date:  2009-03

6.  Glucose intolerance, insulin resistance, and pathological features of Alzheimer disease in the Baltimore Longitudinal Study of Aging.

Authors:  Madhav Thambisetty; E Jeffrey Metter; An Yang; Hillary Dolan; Christopher Marano; Alan B Zonderman; Juan C Troncoso; Yun Zhou; Dean F Wong; Luigi Ferrucci; Josephine Egan; Susan M Resnick; Richard J O'Brien
Journal:  JAMA Neurol       Date:  2013-09-01       Impact factor: 18.302

7.  High-fat diet induces hepatic insulin resistance and impairment of synaptic plasticity.

Authors:  Zhigang Liu; Ishan Y Patil; Tianyi Jiang; Harsh Sancheti; John P Walsh; Bangyan L Stiles; Fei Yin; Enrique Cadenas
Journal:  PLoS One       Date:  2015-05-29       Impact factor: 3.240

Review 8.  The influence of insulin resistance on cerebrospinal fluid and plasma biomarkers of Alzheimer's pathology.

Authors:  Sarah Westwood; Benjamine Liu; Alison L Baird; Sneha Anand; Alejo J Nevado-Holgado; Danielle Newby; Maria Pikkarainen; Merja Hallikainen; Johanna Kuusisto; Johannes R Streffer; Gerald Novak; Kaj Blennow; Ulf Andreasson; Henrik Zetterberg; Ulf Smith; Markku Laakso; Hilkka Soininen; Simon Lovestone
Journal:  Alzheimers Res Ther       Date:  2017-04-26       Impact factor: 6.982

Review 9.  NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.

Authors:  Clifford R Jack; David A Bennett; Kaj Blennow; Maria C Carrillo; Billy Dunn; Samantha Budd Haeberlein; David M Holtzman; William Jagust; Frank Jessen; Jason Karlawish; Enchi Liu; Jose Luis Molinuevo; Thomas Montine; Creighton Phelps; Katherine P Rankin; Christopher C Rowe; Philip Scheltens; Eric Siemers; Heather M Snyder; Reisa Sperling
Journal:  Alzheimers Dement       Date:  2018-04       Impact factor: 21.566

10.  Amyloid and tau imaging biomarkers explain cognitive decline from late middle-age.

Authors:  Tobey J Betthauser; Rebecca L Koscik; Erin M Jonaitis; Samantha L Allison; Karly A Cody; Claire M Erickson; Howard A Rowley; Charles K Stone; Kimberly D Mueller; Lindsay R Clark; Cynthia M Carlsson; Nathaniel A Chin; Sanjay Asthana; Bradley T Christian; Sterling C Johnson
Journal:  Brain       Date:  2020-01-01       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.